Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

You are here: Home » News & Analysis

News & Analysis

Print

China biotech company and industry news and analysis...

Recent Articles

  CFDA is Hiring Drug Reviewers
  China Generic Drugmakers Poaching Indian Execs
  Hengrui Medicine Licenses Cancer Drug to Incyte in $795 Million Deal
  Ascletis Pharma Raises $35 Million; Seeks More In-Licensings
  iKang Receives $1.1 Billion Go-Private Offer
  MicuRx Says Novel Antibiotic Passes China Phase II Test
  Ascletis Approved for Taiwan Trial of Interferon-Free HCV Regimen
  Shanghai Pharma to Form $470 Million China Healthcare VC Fund
  Shanghai Kehua Signs MOU to Acquire Technogenetics of Italy
  CFDA to Start 60-Day Approvals for INDs of Oncology Drugs
 
Login

  

    
   
Partner Events

BioPharm America™ 2015
September 15–17, 2015
Boston, USA

Dorsey 4D Symposium
October 1, 2015
Palo Alto, USA
>> More events...
Our Partners
Annual Sponsors
Official Partners
Supporting Partners
Media Sponsors